Smart oxygen device may protect tiny lungs in preterm babies

NCT ID NCT06622161

Completed Symptom relief Sponsor: Aga Khan University Hospital, Pakistan Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether an automated oxygen control device (Oxygenie) could keep preterm babies' oxygen levels in a safer range better than manual adjustments by nurses. 26 preterm babies on ventilators were randomly assigned to 12 hours of automated or manual oxygen control, then switched. The main goal was to see how much time their oxygen levels stayed within the target range of 90-94%.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Oxygenie automated oxygen control device
What this could lead to: If it works, this could help preterm babies avoid dangerous oxygen swings, reducing risks of eye and lung problems.
What could go wrong: This is a small, completed crossover study with only 26 babies, so results may not apply to all preterm infants. The device may not work as well in real-world settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRETERM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hyperoxia Hypoxia Premature Birth

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PRETERM

Contacts and locations

Locations

Aga Khan University Hospital

Karachi, Sindh, 74800, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.